Clinical Management of COVID-19 in Cancer Patients with the STAT3 Inhibitor Silibinin

COVID-19 pathophysiology is caused by a cascade of respiratory and multiorgan failures arising, at least in part, from the SARS-CoV-2-driven dysregulation of the master transcriptional factor STAT3. Pharmacological correction of STAT3 over-stimulation, which is at the root of acute respiratory distr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosch-Barrera, Joaquim, Roqué, Ariadna, Teixidor, Eduard, Carmona-Garcia, Maria Carmen, Arbusà, Aina, Brunet, Joan, Martin-Castillo, Begoña, Cuyàs, Elisabet, Verdura, Sara, Menendez, Javier A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778965/
https://www.ncbi.nlm.nih.gov/pubmed/35056076
http://dx.doi.org/10.3390/ph15010019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778965/
https://www.ncbi.nlm.nih.gov/pubmed/35056076
http://dx.doi.org/10.3390/ph15010019

Ejemplares similares